Ad Scientiam Revenue

Medical Equipment Manufacturing • Paris, Île-de-France, France • 51-100 Employees

Ad Scientiam revenue & valuation

Annual revenue	$414,187
Revenue per employee	$8,000
Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues	$1,400,000
Total funding	$2,300,000

Key Contacts at Ad Scientiam

Clarissa Gorin

Medical Affairs And Market Access Innovation Director

Matthieu Lamy

Chief Executive Officer

Térence Brochu

Co-Founder - Ux Designer

Hadrien Oger

Administrative And Legal Director - Data Protection Officer

Jordan Bachelet

Senior Product Owner

Bastien Ricono

Head Of Product

Company overview

Headquarters	21, Rue Albert Bayet, Paris, Île-de-France 75013, FR
Phone number	+33157274194
Website	adscientiam.com
NAICS	3391
SIC	283
Keywords	Digital Transformation, Clinical Research, Medical Device, Connected Health, Ehealth, Real World Data, Applications Mhealth, Digital Biomarkers
Founded	2013
Employees	51-100
Socials

Ad Scientiam Email Formats

Ad Scientiam uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@adscientiam.fr), used 95.6% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@adscientiam.fr	95.6%
{first initial}{last name}	jdoe@adscientiam.com	4.4%

About Ad Scientiam

At the heart of Ad Scientiam's project is a conviction: measuring and monitoring the evolution of serious and disabling diseases on a continuous basis and in real life is essential for better management. We make visible these evolutions, until now undetectable, through the design and clinical validation of digital biomarkers. This scientific and technological challenge should enable each patient to be an active participant in their own illness and allow healthcare professionals to offer more individualized and therefore more efficient care. Ad Scientiam thus participates in the development of future treatments and in reducing the societal and economic impact of diseases. Hospital institutions such as the Brain Institute (ICM) and pharmaceutical companies such as Biogen, Janssen, Roche, Pfizer, Vertex and Novartis have already trusted us. In 2018, Ad Scientiam launched MSCopilot®, the first and only CE-marked software medical device for the self-assessment of multiple sclerosis patients. New devices are currently being validated in neuroscience, rare diseases and mental disorders.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Manager

Entry

Head

Employees by Department

Ad Scientiam has 44 employees across 13 departments.

Departments

Number of employees

Funding Data

Explore Ad Scientiam's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2017-08-18	1	$2,300,000

Funding Insights

$2,300,000

Total funding amount

$2,300,000

Most recent funding amount

Number of funding rounds

Ad Scientiam Tech Stack

Discover the technologies and tools that power Ad Scientiam's digital infrastructure, from frameworks to analytics platforms.

parcel

Miscellaneous

Astra

WordPress themes

Underscore.js

JavaScript libraries

WPForms

Form builders

Swiper

JavaScript libraries

jQuery UI

JavaScript libraries

SWC

Miscellaneous

Elementor

Page builders

Zendesk

Documentation

jQuery Migrate

JavaScript libraries

Apache HTTP Server

Web servers

Twitter Emoji

Font scripts

Frequently asked questions

Ad Scientiam is located in Paris, Île-de-France, FR.

You can reach Ad Scientiam at +33157274194.

Ad Scientiam generates an estimated annual revenue of $414,187. This revenue figure reflects the company's market position and business performance in its industry.

Ad Scientiam has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Ad Scientiam was founded in 2013, making it 13 years old. The company has established itself as a significant player in its industry over this time.

Ad Scientiam has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

Ad Scientiam has raised a total of $2,300,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Ad Scientiam

Clarissa Gorin

Medical Affairs And Market Access Innovation Director

Matthieu Lamy

Chief Executive Officer

Térence Brochu

Co-Founder - Ux Designer

Hadrien Oger

Administrative And Legal Director - Data Protection Officer

Jordan Bachelet